NeuroVive Pharmaceutical AB EBIT margin
Quel est le EBIT margin de NeuroVive Pharmaceutical AB?
Le EBIT margin de NeuroVive Pharmaceutical AB est -81,610.53%
Quelle est la définition de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin des entreprises dans Miscellaneous secteur sur LSE par rapport à NeuroVive Pharmaceutical AB
Que fait NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Entreprises avec ebit margin similaire à NeuroVive Pharmaceutical AB
- Catheter Precision a EBIT margin de -97,518.89%
- Lordstown Motors a EBIT margin de -96,628.46%
- Biosig Technologies Inc a EBIT margin de -93,003.70%
- Allied Hotel Properties a EBIT margin de -92,833.33%
- Hyliion a EBIT margin de -89,479.17%
- Shyam Telecom a EBIT margin de -87,410.20%
- NeuroVive Pharmaceutical AB a EBIT margin de -81,610.53%
- Seneca Biopharma Inc a EBIT margin de -78,961.14%
- AB Active ETFs Inc a EBIT margin de -78,222.42%
- Loop Insights a EBIT margin de -77,918.34%
- Eidos Therapeutics Inc a EBIT margin de -77,648.82%
- NantKwest Inc a EBIT margin de -76,960.36%
- Oil Country Tubular a EBIT margin de -75,819.11%